๐ฐ Sandy Borgschulte News
Sandy Borgschulte News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sandy Borgschulte. Real-time updates on events, politics, business and more.
May 12, 2022
ST. LOUIS, May 12, 2022 (GLOBE NEWSWIRE) -- Curium confirmed today no supply challenges of 177Lu-PSMA-I&T for the Phase 3 ECLIPSE clinical trial...
May 12, 2022
Investegate announcements from Curium, Curium Confirms No Supply Challenges of 177Lu-PSMA-I&T for ECLIPSE Trial
May 3, 2022
Investegate announcements from Curium, Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
May 3, 2022
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized clinical
April 19, 2022
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market. Curium will now be
April 5, 2022
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug Administration
April 5, 2022
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on...
December 15, 2021
London and Paris, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Curium welcomes Sakir Mutevelic MD, MSc. As Chief Medical Officer, Sakir leads Curiumโs global...
December 15, 2021
London and Paris, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Curium welcomes Sakir Mutevelic MD, MSc. As Chief Medical Officer, Sakir leads Curium's global medical strategy and clinical development for diagnostic